Scholarlink

<p>Chronic diseases such as diabetes, inflammation, and oxidative stress continue to pose major global health challenges, while conventional therapies remain limited by poor bioavailability and side effects. Natural polyphenols like resveratrol and quercetin are well known for their antioxidant, anti-inflammatory, and antidiabetic properties, yet their clinical potential is restricted due to rapid metabolism and low solubility. Nanotechnology-based approaches offer a promising solution by enhancing stability, solubility, and targeted delivery of such bioactive compounds. In this study, resveratrol–quercetin functionalized selenium nanoparticles (QR-SeNPs) were synthesised using a green reduction method, with the phytochemicals serving as both reducing and stabilising agents. The nanoparticles were characterised by UV–Vis spectroscopy, SEM, FTIR, DLS, zeta potential, and XRD, confirming spherical morphology, nanoscale size (200–300&#xa0;nm), good colloidal stability (−&#xa0;30 to −&#xa0;40&#xa0;mV), and predominantly amorphous structure. Biological evaluations revealed that QR-SeNPs exhibited strong anti-inflammatory activity, achieving ~ 80% inhibition of protein denaturation at 50&#xa0;µg/mL, alongside potent antioxidant activity with ~ 90% scavenging in DPPH and H₂O₂ assays. In antidiabetic assays, they demonstrated significant enzyme inhibition (81% for α-amylase and 75% for β-glucosidase), comparable to standard drugs. Cytotoxicity assessment showed minimal lethality at therapeutic concentrations, with moderate effects observed only at higher doses. These findings indicate that green-synthesised QR-SeNPs represent a multifunctional and biocompatible nanoplatform with strong potential for managing oxidative stress, inflammation, and diabetes, warranting further in vivo and mechanistic investigations.</p>

错误：搜索内容不能为空，请输入英文关键词
错误：关键词超出字数限制，请精简
高级检索

Synergistic Therapeutic Potential of Resveratrol–Quercetin Loaded Selenium Nanoparticles: Synthesis, Characterisation, and In Vitro Pharmacological Evaluation

  • 期刊论文

  • 发表日期：

    2026年6月16日

查看全文
  • Thirumalaikumaran Rathinam,
  • Vandhana Vijayakumar,
  • Abida Haripriya Rammohan,
  • Dharshini Sagadevan,
  • Udhayakumar Thangavelu

摘要

Chronic diseases such as diabetes, inflammation, and oxidative stress continue to pose major global health challenges, while conventional therapies remain limited by poor bioavailability and side effects. Natural polyphenols like resveratrol and quercetin are well known for their antioxidant, anti-inflammatory, and antidiabetic properties, yet their clinical potential is restricted due to rapid metabolism and low solubility. Nanotechnology-based approaches offer a promising solution by enhancing stability, solubility, and targeted delivery of such bioactive compounds. In this study, resveratrol–quercetin functionalized selenium nanoparticles (QR-SeNPs) were synthesised using a green reduction method, with the phytochemicals serving as both reducing and stabilising agents. The nanoparticles were characterised by UV–Vis spectroscopy, SEM, FTIR, DLS, zeta potential, and XRD, confirming spherical morphology, nanoscale size (200–300 nm), good colloidal stability (− 30 to − 40 mV), and predominantly amorphous structure. Biological evaluations revealed that QR-SeNPs exhibited strong anti-inflammatory activity, achieving ~ 80% inhibition of protein denaturation at 50 µg/mL, alongside potent antioxidant activity with ~ 90% scavenging in DPPH and H₂O₂ assays. In antidiabetic assays, they demonstrated significant enzyme inhibition (81% for α-amylase and 75% for β-glucosidase), comparable to standard drugs. Cytotoxicity assessment showed minimal lethality at therapeutic concentrations, with moderate effects observed only at higher doses. These findings indicate that green-synthesised QR-SeNPs represent a multifunctional and biocompatible nanoplatform with strong potential for managing oxidative stress, inflammation, and diabetes, warranting further in vivo and mechanistic investigations.